Home/Filings/4/0001209191-20-035149
4//SEC Filing

Cui Jingrong Jean 4

Accession 0001209191-20-035149

CIK 0001595893other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 8:26 PM ET

Size

35.6 KB

Accession

0001209191-20-035149

Insider Transaction Report

Form 4
Period: 2020-06-04
Cui Jingrong Jean
DirectorChief Scientific Officer
Transactions
  • Sale

    Common Stock

    2020-06-05$65.66/sh1,300$85,358568,383 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$63.88/sh3,688$235,589596,195 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$68.62/sh2,072$142,181587,711 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$61.76/sh1,900$117,344603,483 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-05$65.03/sh4,671$303,755569,683 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-08$62.50/sh1,872$117,000566,511 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-08$63.92/sh5,961$381,027549,883 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$62.70/sh3,600$225,720599,883 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$69.54/sh828$57,579586,883 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-08$63.36/sh10,667$675,861555,844 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$64.67/sh4,012$259,456592,183 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$65.81/sh600$39,486591,583 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-04$67.52/sh1,800$121,536589,783 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-05$63.04/sh3,602$227,070583,281 total(indirect: By Spouse)
  • Sale

    Common Stock

    2020-06-05$64.04/sh8,927$571,685574,354 total(indirect: By Spouse)
Holdings
  • Common Stock

    (indirect: By The Jean Cui 2020 GRAT)
    300,000
  • Common Stock

    1,001,298
Footnotes (16)
  • [F1]Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
  • [F10]The weighted average sale price for the transaction reported was $63.04, and the range of prices were between $62.445 and $63.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F11]The weighted average sale price for the transaction reported was $64.04, and the range of prices were between $63.46 and $64.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F12]The weighted average sale price for the transaction reported was $65.03, and the range of prices were between $64.46 and $65.41. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F13]The weighted average sale price for the transaction reported was $65.66, and the range of prices were between $65.51 and $66.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F14]The weighted average sale price for the transaction reported was $62.50, and the range of prices were between $61.71 and $62.705. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F15]The weighted average sale price for the transaction reported was $63.36, and the range of prices were between $62.71 and $63.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F16]The weighted average sale price for the transaction reported was $63.92, and the range of prices were between $63.71 and $64.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F2]The weighted average sale price for the transaction reported was $61.76, and the range of prices were between $61.32 and $62.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The weighted average sale price for the transaction reported was $62.70, and the range of prices were between $62.32 and $63.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F4]The weighted average sale price for the transaction reported was $63.88, and the range of prices were between $63.35 and $64.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F5]The weighted average sale price for the transaction reported was $64.67, and the range of prices were between $64.35 and $65.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F6]The weighted average sale price for the transaction reported was $65.81, and the range of prices were between $65.38 and $66.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F7]The weighted average sale price for the transaction reported was $67.52, and the range of prices were between $67.10 and $67.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F8]The weighted average sale price for the transaction reported was $68.62, and the range of prices were between $68.11 and $69.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F9]The weighted average sale price for the transaction reported was $69.54, and the range of prices were between $69.14 and $69.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Turning Point Therapeutics, Inc.

CIK 0001595893

Entity typeother

Related Parties

1
  • filerCIK 0001772259

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 8:26 PM ET
Size
35.6 KB